A detailed history of Xponance, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Xponance, Inc. holds 90,147 shares of DXCM stock, worth $7.23 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
90,147
Previous 89,460 0.77%
Holding current value
$7.23 Million
Previous $10.1 Million 40.44%
% of portfolio
0.06%
Previous 0.1%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $43,968 - $79,733
687 Added 0.77%
90,147 $6.04 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $236,173 - $300,703
2,141 Added 2.45%
89,460 $10.1 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $182,066 - $223,319
1,594 Added 1.86%
87,319 $12.1 Million
Q4 2023

Jan 31, 2024

SELL
$75.49 - $124.16 $217,260 - $357,332
-2,878 Reduced 3.25%
85,725 $10.6 Million
Q3 2023

Oct 23, 2023

BUY
$86.06 - $137.93 $146,388 - $234,618
1,701 Added 1.96%
88,603 $8.27 Million
Q2 2023

Jul 13, 2023

BUY
$112.47 - $130.98 $207,169 - $241,265
1,842 Added 2.17%
86,902 $11.2 Million
Q1 2023

Apr 17, 2023

BUY
$104.0 - $122.92 $129,480 - $153,035
1,245 Added 1.49%
85,060 $9.88 Million
Q4 2022

Jan 23, 2023

BUY
$84.98 - $122.67 $457,957 - $661,068
5,389 Added 6.87%
83,815 $0
Q3 2022

Oct 24, 2022

SELL
$76.35 - $94.18 $32,754 - $40,403
-429 Reduced 0.54%
78,426 $6.32 Million
Q2 2022

Aug 02, 2022

BUY
$67.99 - $132.89 $3.99 Million - $7.79 Million
58,640 Added 290.08%
78,855 $5.88 Million
Q1 2022

Apr 20, 2022

BUY
$94.08 - $130.2 $20,133 - $27,862
214 Added 1.07%
20,215 $10.3 Million
Q4 2021

Jan 31, 2022

BUY
$129.87 - $162.82 $680,778 - $853,502
5,242 Added 35.52%
20,001 $10.7 Million
Q3 2021

Nov 05, 2021

SELL
$106.71 - $143.18 $44,498 - $59,706
-417 Reduced 2.75%
14,759 $8.07 Million
Q2 2021

Aug 12, 2021

BUY
$80.99 - $107.93 $119,784 - $159,628
1,479 Added 10.8%
15,176 $6.48 Million
Q1 2021

May 10, 2021

SELL
$84.79 - $104.74 $678 - $837
-8 Reduced 0.06%
13,697 $4.92 Million
Q4 2020

Feb 11, 2021

BUY
$78.0 - $104.5 $19,812 - $26,543
254 Added 1.89%
13,705 $5.07 Million
Q3 2020

Oct 26, 2020

BUY
$95.51 - $112.95 $16,905 - $19,992
177 Added 1.33%
13,451 $5.55 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $832,014 - $1.4 Million
13,274 New
13,274 $5.38 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.